Le Lézard
Classified in: Health
Subject: CCA

WELL Health to Host Third Quarter 2019 Investor Conference Call


VANCOUVER, Nov. 8, 2019 /CNW/ - WELL Health Technologies Corp. ("WELL") (TSX.V: WELL), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, will hold a conference call to discuss its 2019 third quarter financial results on Tuesday, November 12, 2019 at 12:30pm ET (9:30 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer; Eva Fong, Chief Financial Officer and Pardeep S. Sangha Vice President Corporate Strategy and Investor Relations.

Conference Call Details:

Date:

Tuesday, November 12, 2019

Time:

12:30 pm Eastern Time (9:30 am Pacific Time)

Dial-in:

416-764-8609 (Toronto local)


778-383-7417 (Vancouver local)  


1-888-390-0605 (Toll-Free)

Conf. ID:

73454719

 

About WELL

WELL is a unique company that operates Primary Healthcare Facilities as well as a significant Electronic Medical Records (EMR) business that supports the digitization of such clinics.  WELL wholly owns nineteen medical clinics, is a majority owner of one clinic and provides digital EMR software and services to approximately 852 medical clinics across Canada. WELL's overarching objective is to empower physicians and other care providers to deliver the best and most advanced care possible by leveraging the latest trends in digital health.  WELL is publicly traded on the TSX Venture Exchange under the symbol "WELL.v".  WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE WELL Health Technologies Corp.


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: